Browse > Article
http://dx.doi.org/10.22537/jksct.16.1.33

Comparison of Silymarin, Penicillin, N-acetylcysteine in Patient with Amatoxin Poisoning: A Systematic Review  

Choi, Min Woo (Department of Emergency Medicine, Yonsei University College of Medicine)
Ko, Dong Ryul (Department of Emergency Medicine, Yonsei University College of Medicine)
Kong, Taeyoung (Department of Emergency Medicine, Yonsei University College of Medicine)
Choa, Min Hong (Department of Emergency Medicine, Yonsei University College of Medicine)
You, Je Sung (Department of Emergency Medicine, Yonsei University College of Medicine)
Chung, Sung Phil (Department of Emergency Medicine, Yonsei University College of Medicine)
Publication Information
Journal of The Korean Society of Clinical Toxicology / v.16, no.1, 2018 , pp. 33-41 More about this Journal
Abstract
Purpose: This study was conducted to evaluate the clinical efficacy of pharmacologic treatment of amatoxin poisoning patients. Methods: Literature was accessed through PubMed, EMBASE, Cochrane library, KoreaMed, KISS and KMBASE. Studies relevant to human use of pharmacologic therapy including silymarin, penicillin and N-acetylcysteine (NAC) for amanita poisoning were included. Case reports, letters, editorials and papers with insufficient information were excluded. Comparison of clinical outcomes (especially mortality and liver transplantation rate) in each study was analyzed. Results: The final analysis included 13 retrospective studies. None of these studies showed direct comparisons of individual agents. Among 12 studies comparing silymarin vs penicillin, eight showed clinical superiority of silymarin. Among eight studies comparing silymarin with NAC, six showed clinical superiority of silymarin. Among seven studies of NAC vs penicillin, five showed clinical superiority of NAC. Conclusion: This systematic review suggested that clinical superiority of various pharmacological agents used to treat amatoxin poisoning is debatable. Nevertheless, the available evidence suggests it is reasonable to consider combinations of multiple agents for patients with amanita poisoning. Further studies are required to establish a treatment regimen for amanita poisoning.
Keywords
Amatoxin; Poisoning; Silymarin; Silibinin; Penicillin; Acetylcysteine;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Garcia J, Costa VM, Carvalho A, Baptista P, de Pinho PG, de Lourdes Bastos M, et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food Chem Toxicol 2015;86:41-55.   DOI
2 Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-12.   DOI
3 Available at: http://www.sign.ac.uk/checklists-and-notes.html. Accessed April 13, 2018.
4 Berger KJ, Guss DA. Mycotoxins revisited: part I. J Emerg Med 2005;28:53-62.   DOI
5 Polyak SJ, Oberlies NH, Pecheur EI, Dahari H, Ferenci P, Pawlotsky JM. Silymarin for HCV infection. Antivir Ther 2013;18:141-7.   DOI
6 Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver disease. Drugs 2001;61:2035-63.   DOI
7 Post-White J. Advances in the use of milk thistle. Intergrr Cancer Ther 2007;6:104-9.   DOI
8 Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev 2005;2:CD003620.
9 Zuber R, Modriansky M, Dvorak Z, Rohovsky P, Ulrichova J, Simanek V, et al. Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities. Phytother Res 2002;16:632-8.   DOI
10 Enjalbert F, Rapior S, Nouguier-Soule J, Guillon S, Amouroux N, Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol 2002;40:715-57.   DOI
11 Poucheret P, Fons F, Dore JC, Michelot D, Rapior S. Amatoxin poisoning treatment decision-making: Pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis. Toxicon 2010;55:1338-45.   DOI
12 Zilker TR, Felgenhauer NJ, Michael H, Strenge-Hesse A. Grading of severity and therapy of 154 cases of Amanita poisoning. Vet Hum Toxicol 1993;35:331-6.
13 Sohn CH. Type and treatment of toxic mushroom poisoning in Korea. J Korean Med Assoc 2015; 58:818-24.   DOI
14 Garcia J, Costa VM, Carvalho AT, Silvestre R, Duarte JA, Dourado DF, et al. A breakthrough on Amanita phalloides poisoning: an effective antidotal effect by polymyxin B. Arch Toxicol 2015;89:2305-23.   DOI
15 Smith MR, Davis RL. Mycetismus: a review. Gastroenterol Rep 2016;4:107-12.   DOI
16 Mengs U, Pohl RT, Mitchell T. $Legalon^{(R)}$ SIL: the antidote of choice in patients with acute hepatotoxicvity from amatoxins poisoning. Curr Pharm Biotechnol 2012;13:1964-70.   DOI
17 Ye Y, Liu Z. Management of Amanita phalloides poisoning; A literature review and update. J Crit Care 2018;46:17-22.   DOI
18 Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus--a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-90.   DOI
19 Pillukat MH, Schomacher T, Baier P, Gabriels G, Pavenstadt H, Schmidt HH. Early initiation of MARS(R) dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation. Ann Hepatol 2016;15:775-87.
20 Available at: http://drug.mfds.go.kr/html/index.jsp. Accessed May 20, 2018.
21 Zilker TH. Prognosis and treatment of amatoxin poisoning. Clin Toxicol 2009;47:467.
22 Ganzert M. Felgenhauer N. Schuster T, Eyer F, Gourdin C, Zilker T. Amanita poisoning-conparison of silibinin with a combination silibinin and penicillin. Dtsch Med Wochenschr 2008;133:2261-7.   DOI
23 Rengstorff DS, Osorio RW, Bonacini M. Recovery from severe hepatitis caused by mushroom poisoning without liver transplantation. Clin Gastroenterol Hepatol 2003;1:392-6.   DOI
24 Ahishali E, Boynuegri B, Ozpolat E, Surmeli H, Dolapcioglu C, Dabak R, et al. Approach to mushroom intoxication and treatment: can we decrease mortality? Clin Res Hepatol Gastroenterol 2012;36:139-45.   DOI
25 Robert DM, Hall MJ, Falkland MM, Strasser SI, Buckley NA. Amanita phalloides poisoning and treatment with silibinin in the Australian capital territory and New South Wales. Med J Austr 2013;198:43-7.   DOI
26 Karvellas CJ, Tillman H, Leung AA, Lee WM, Schilsky ML, Hameed B, et al. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int 2016;36:1043-50.   DOI
27 Akin A, Keskek SO, Kilic DA, Aliustaoglu M, Keskek NS. The effect of N-acetylcysteine in patients with Amanita phalloides intoxication. J Drug Metab Toxicol 2013;4:1-3.
28 Krenova M, Pelclova D, Navratil T. Survey of Amanita phalloides poisoning: clinical findings and follow-up evaluation. Hum Exp Toxicol 2007;26:955-61.   DOI
29 Fix OK, Davern TJ, Doo E, Zaman A, Ganger DR, Reddy R, et al. Acute liver failure due to mushroom poisoning in the United States: Results from the ALFSG registry. Hepatology 2011;54:497A.
30 Trakulsrichai S, Sriapha C, Tongpoo A, Udomsubpayakul U, Wongvisavakorn S, Srisuma S, et al. Clinical characteristics and outcome of toxicity from Amanita mushroom poisoning. Int J Gen Med 2017;10:395-400.   DOI